1-7 of 7
Zeba N Singh
Close
Sort by
Journal Articles

A Subset of Classical Hodgkin Lymphoma Cases Demonstrate CD19 Expression on Hodgkin Reed-Sternberg Cells By Immunohistochemistry

Sarah Helman, Fikru Merechi, Hanan Alharthy, Madhurima Koka, Michael Kallen, Aaron P. Rapoport, Jennie Law, Seung Tae Lee, Zeba N Singh
Journal: Blood
Blood (2023) 142 (Supplement 1): 6125.
https://doi.org/10.1182/blood-2023-174284
Published: 2023
Journal Articles

Primary and Secondary Plasma Cell Leukemia Risk Stratification By Circulating Plasma Cells

Andrew Y Li, Farin Kamangar, Noa G. Holtzman, Aaron P. Rapoport, Mehmet H. Kocoglu, Djordje Atanackovic, Zeba N Singh, Sameer Sawhney, Ying S Zou, Ashraf Z. Badros
Journal: Blood
Blood (2023) 142 (Supplement 1): 6627.
https://doi.org/10.1182/blood-2023-178314
Published: 2023
Journal Articles

B-acute lymphoblastic leukemia with eosinophilic inclusions

Sarah R. Helman, Zeba N. Singh
Journal: Blood
Blood (2023) 141 (13): 1645.
https://doi.org/10.1182/blood.2022018796
Published: 2023
Journal Articles

Non-Producing Multiple Myeloma (MM) Is a Distinct Subset Of Non-Secretory MM Characterized By High Cyclin D1 Expression and Decreased Progression Free Survival

Xenofon Papanikolaou, MD, Qing Zhang, PhD, Christoph Heuck, MD, Sarah Waheed, MD, Shebli Atrash, MD, Zeba N Singh, MD, Daisy V. Alapat, MD, Frits van Rhee, MD, PhD, Shweta S. Chavan, PhD, Joshua Epstein, DSc, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1911.
https://doi.org/10.1182/blood.V122.21.1911.1911
Published: 2013
Journal Articles

Secondary Myelodysplasia-Associated Metaphase Cytogenetic Abnormalities in Newly Diagnosed Multiple Myeloma Treated On Total Therapies 2 & 3– Influence of Cumulative Dosing of Maintenance Drugs

Saad Z Usmani, MD FACP, Adam Rosenthal, Rachael Sexton, Antje Hoering, Zeba N Singh, MD, Sarah Waheed, MD, Al-Ola Abdallah, MD, Jameel Muzaffar, MD, Nathan M Petty, John Crowley, PhD, Jeffrey Sawyer, PhD, Joshua Epstein, DSc, Frits van Rhee, MD, PhD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 324.
https://doi.org/10.1182/blood.V120.21.324.324
Published: 2012
Journal Articles

Fulminant Onset of Acute Leukemia (FOAL) After Total Therapies (TT) for Multiple Myeloma (MM): Absence of MDS Pathological Criteria within 3 Months of Prior MM Follow-up

Zeba N Singh, MD, Jeffrey R Sawyer, Ph.D., Ginell R. Post, MD, PhD, Sarah Waheed, MD, Saad Z Usmani, MD FACP, Frits van Rhee, MD, PhD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 1458.
https://doi.org/10.1182/blood.V120.21.1458.1458
Published: 2012
Journal Articles

Loss of Chemokine Receptor Expression and Tetraspanins Is Correlated with Extramedullary Disease In Multiple Myeloma

Zeba N Singh, MD, Rebecca B Owens, BSMT, Bijay Nair, MD, MPH, John Shaughnessy, Jr., PhD, Bart Barlogie, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 2983.
https://doi.org/10.1182/blood.V116.21.2983.2983
Published: 2010